Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

被引：14

作者：

Montagut, C ^{[1
]}

Bosch, F ^{[1
]}

Villela, L ^{[1
]}

Rosiñol, L ^{[1
]}

Bladé, J ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Clin, IDIBAPS, ICMHO,Dept Hematol, E-08036 Barcelona, Spain

来源：

LEUKEMIA & LYMPHOMA | 2004年 / 45卷 / 08期

关键词：

multiple myeloma; thalidomide; aminoglycoside; renal failure;

D O I：

10.1080/10428190310001638841

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thalidomide has been proved to play an important role in rescue treatment of patients with refractory/relapsed multiple myeloma (MM). However, thalidomide therapy is associated with numerous side effects, mainly somnolence, constipation, fatigue or peripheral neuropathy. We report three patients diagnosed with MM and treated with thalidomide as salvage therapy who developed severe renal failure when they received aminoglycoside antibiotics. This observation suggests that thalidomide can potentiate nephrotoxicity of aminoglycoside antibiotics in patients with MM.

引用

页码：1711 / 1712

页数：2

共 50 条

[21] Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”
Hira S. Mian
Mark A. Fiala
Larysa Sanchez
Ravi Vij
Tanya M. Wildes
Annals of Hematology, 2021, 100 : 1261 - 1266
[22] A Study on Renal Failure Management in Patients Diagnosed With Multiple Myeloma
Almuhaysen, Lama M.
Abu Al Alaa, Amal Badr
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
[23] Clinical Outcomes of Patients with Multiple Myeloma Presenting with Renal Failure
Vasant, Joydeep Singh
Gupta, Naveen
Malhotra, Hemant
Godara, Suraj
Yadav, Ajay
Kumbhaj, Prashant
Punia, Ankur
Soni, Priyanka
Sharma, Lalit Mohan
SOUTH ASIAN JOURNAL OF CANCER, 2025,
[24] Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab
Gallerani, Elisa
Lerch, Erika
Romagnani, Elena
Stathis, Anastasios
Giardelli, Greta
Zwhalen, Hugo
Marone, Claudio
Cavalli, Franco
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (06) : 527 - 529
[25] Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma
Avigdor, A
Raanani, P
Levi, I
Hardan, I
Ben-Bassat, I
LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 683 - +
[26] Thalidomide-induced rash in patients with multiple myeloma
Zhang, Wen-Long
Wang, Wan-Ning
Zhou, Guang-Yu
Sun, Yan-Xia
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20387 - 20390
[27] Can thalidomide improve outcome in patients with multiple myeloma?
Richardson, Paul G.
Mitsiades, Constantine S.
Munshi, Nikhil C.
Anderson, Kenneth C.
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (11): : 590 - 591
[28] Thalidomide-induced severe neutropenia during treatment of multiple myeloma
Hattori, Y
Kakimoto, T
Okamoto, S
Sato, N
Ikeda, Y
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 283 - 288
[29] Thalidomide-induced severe neutropenia during treatment of multiple myeloma
Yutaka Hattori
Tsunayuki Kakimoto
Shinichiro Okamoto
Norihide Sato
Yasuo Ikeda
International Journal of Hematology, 2004, 79 : 283 - 288
[30] LONG-TERM SURVIVAL PATIENTS WITH ACUTE AND SEVERE RENAL-FAILURE DUE TO MULTIPLE-MYELOMA
PASQUALI, S
CASANOVA, S
ZUCCHELLI, A
ZUCCHELLI, P
CLINICAL NEPHROLOGY, 1990, 34 (06) : 247 - 254

← 1 2 3 4 5 →